InsiderClue
Insiders · Profile

Freund John Gordon

Director at COLLEGIUM PHARMACEUTICAL · Director at SI-BONE · Director at SUTRO BIOPHARMA · and 1 more. Filing since 27 Oct 2014. CIK 0001296771

COLL COLLEGIUM PHARMACEUTICAL, INC Director · 5 trades SIBN SI-BONE, Inc. Director · 25 trades STRO SUTRO BIOPHARMA, INC. Director · 3 trades TARA Protara Therapeutics, Inc. Director · 2 trades
Company
Date
Role
Action
Shares
Amount
Of holding
COLL COLLEGIUM PHARMACEUTICAL, INC
18 May 2026
Director
Sold at will
20
$681.00
0.0%
COLL COLLEGIUM PHARMACEUTICAL, INC
15 May 2026
Director
Sold at will
4,127
$142.55K
4.7%
COLL COLLEGIUM PHARMACEUTICAL, INC
8 Aug 2025
Director
Sold at will
11,659
$400.64K
33.5%
SIBN SI-BONE, Inc.
8 Aug 2025
Director
Sold at will
12,132
$194.00K
11.7%
COLL COLLEGIUM PHARMACEUTICAL, INC
9 Jun 2025
Director
Sold at will
6,601
$202.15K
8.5%
SIBN SI-BONE, Inc.
9 Aug 2023
Director
Sold at will
30,000
$616.20K
22.4%
SIBN SI-BONE, Inc.
16 Jun 2021
Director
Sold, plan not stated
12,591
$395.43K
3.7%
SIBN SI-BONE, Inc.
15 Jun 2021
Director
Sold, plan not stated
21,511
$669.14K
5.9%
SIBN SI-BONE, Inc.
14 Jun 2021
Director
Sold, plan not stated
17,990
$562.74K
4.7%
SIBN SI-BONE, Inc.
28 May 2021
Director
Sold, plan not stated
45,220
$1.36M
10.5%
SIBN SI-BONE, Inc.
27 May 2021
Director
Sold, plan not stated
26,367
$815.52K
5.8%
SIBN SI-BONE, Inc.
26 May 2021
Director
Sold, plan not stated
17,138
$545.83K
3.6%
SIBN SI-BONE, Inc.
25 May 2021
Director
Sold, plan not stated
1,696
$55.20K
0.4%
SIBN SI-BONE, Inc.
24 May 2021
Director
Sold, plan not stated
51,027
$1.66M
9.7%
SIBN SI-BONE, Inc.
17 Mar 2021
Director
Sold, plan not stated
666,200
$20.24M
55.9%
SIBN SI-BONE, Inc.
16 Mar 2021
Director
Sold, plan not stated
55,053
$1.67M
4.4%
SIBN SI-BONE, Inc.
15 Mar 2021
Director
Sold, plan not stated
80,887
$2.50M
6.1%
SIBN SI-BONE, Inc.
12 Mar 2021
Director
Sold, plan not stated
91,072
$2.86M
6.4%
SIBN SI-BONE, Inc.
11 Mar 2021
Director
Sold, plan not stated
63,928
$1.98M
4.3%
SIBN SI-BONE, Inc.
3 Dec 2020
Director
Sold, plan not stated
47,886
$1.12M
3.1%
SIBN SI-BONE, Inc.
2 Dec 2020
Director
Sold, plan not stated
100,000
$2.33M
6.1%
SIBN SI-BONE, Inc.
19 Oct 2020
Director
Sold, plan not stated
190,053
$4.18M
8.2%
STRO SUTRO BIOPHARMA, INC.
18 Sep 2020
Director
Sold, plan not stated
400,000
$4.80M
41.7%
STRO SUTRO BIOPHARMA, INC.
11 Sep 2020
Director
Sold, plan not stated
500,000
$5.00M
34.2%
STRO SUTRO BIOPHARMA, INC.
19 Aug 2020
Director
Sold, plan not stated
500,000
$4.36M
25.5%
SIBN SI-BONE, Inc.
26 Aug 2019
Director
Sold, plan not stated
152,424
$2.81M
3.8%
SIBN SI-BONE, Inc.
23 Aug 2019
Director
Sold, plan not stated
180
$3.61K
0.0%
SIBN SI-BONE, Inc.
22 Aug 2019
Director
Sold, plan not stated
2,185
$43.81K
0.1%
SIBN SI-BONE, Inc.
21 Aug 2019
Director
Sold, plan not stated
27,067
$545.04K
0.7%
SIBN SI-BONE, Inc.
21 Aug 2019
Director
Sold, plan not stated
18,144
$366.02K
0.5%
SIBN SI-BONE, Inc.
12 Aug 2019
Director
Sold, plan not stated
400,000
$7.30M
9.0%
SIBN SI-BONE, Inc.
19 Oct 2018
Director
Bought
325,000
$4.88M
7.9%
COLL COLLEGIUM PHARMACEUTICAL, INC
12 May 2015
Director
Bought
150,000
$1.80M
5.4%
TARA Protara Therapeutics, Inc.
27 Oct 2014
Director
Bought
200,000
$2.00M
opened
TARA Protara Therapeutics, Inc.
27 Oct 2014
Director
Sold, plan not stated
56,038
$560.38K
3.8%
35 decisions on file.